Moderna tests mRNA shots to stop stomach bug outbreaks
NCT ID NCT05992935
Summary
This study is testing two new mRNA vaccines, mRNA-1403 and mRNA-1405, designed to prevent norovirus, a common cause of severe stomach flu. It will involve about 1,400 healthy adults aged 18 to 80 to check if the vaccines are safe and if they trigger a good immune response. The research is in early-to-mid stages (Phase 1/2) and is currently not recruiting new participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NOROVIRUS ACUTE GASTROENTERITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ARK Clinical Research, LLC
Long Beach, California, 90815, United States
-
Accel Research Sites Network
Decatur, Georgia, 30030, United States
-
Emeritus Research Camberwell
Camberwell, Australia
-
Epic Medical Research, LLC
Red Oak, Texas, 75154, United States
-
JBR Clinical Research
Salt Lake City, Utah, 84107, United States
-
Johnson County Clin-Trials (JCCT)
Lenexa, Kansas, 66219, United States
-
Nucleus Network
Melbourne, Australia
-
Optimal Research
Peoria, Illinois, 61614, United States
-
Research Centers of America
Hollywood, Florida, 33024, United States
-
Rochester Clinical Research, Inc
Rochester, New York, 14609, United States
-
Tekton Research, Inc - Longmont Center
Longmont, Colorado, 80501, United States
-
Velocity Clinical Research
Sioux City, Iowa, 51106, United States
-
Velocity Clinical Research
Rockville, Maryland, 20854, United States
-
Velocity Clinical Research
Norfolk, Nebraska, 68701, United States
-
Velocity Clinical Research
Omaha, Nebraska, 68134, United States
-
Velocity Clinical Research - Boise
Meridian, Idaho, 83642, United States
Conditions
Explore the condition pages connected to this study.